EODData

MEMBERSHIP REGISTER LOG IN

ASX, CU6: Clarity Pharmaceuticals Ltd.

24 Dec 2025
LAST:

3.360

CHANGE:
 0.17		OPEN:
3.190		HIGH:
3.410		ASK:
3.420		VOLUME:
1.85M
CHG(%):
5.33		PREV:
3.190		LOW:
3.150		BID:
3.370		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
24 Dec 253.1903.4103.1503.3601.85M
23 Dec 253.1803.2803.1103.1901.87M
22 Dec 253.6003.7203.1503.1605.18M
19 Dec 253.3103.4603.2353.3405.75M
18 Dec 253.2303.3153.1153.2701.65M
17 Dec 252.9403.3302.9203.2202.19M
16 Dec 253.1503.1502.9102.9201.15M
15 Dec 253.1103.1203.0103.080419.9K
12 Dec 253.2503.3103.1003.1201.34M
11 Dec 253.1903.3803.1403.2102.65M

PROFILE

Name:Clarity Pharmaceuticals Ltd.
About:Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States. The company's lead product is SAR-bisPSMA, a theranostic radiopharmaceutical for the treatment of Prostate Specific Membrane Antigen (PSMA) cancer. It also develops SAR-Bombesin, a pan cancer theranostic radiopharmaceutical to treat prostate, breast, ovarian, urinary, small cell lung cancer, as well as glioblastoma and gastrointestinal stromal tumours; and SARTATE, a theranostic radiopharmaceutical for the treatment of somatostatin receptor 2 (SSTR2) cancer. The company was incorporated in 2010 and is based in Sydney, Australia.
Sector:Healthcare
Industry:Biotechnology
Address:National Innovation Centre, Sydney, NSW, Australia, 2015
Website:https://www.claritypharmaceuticals.com
ISIN:AU0000165375
FIGI:BBG011WVJ0K9

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-24.08 
Forward P/E:-53.56 
PEG Ratio:-53.56 
Price to Sales:192.59 
Price to Book:17.15 
Operating Margin:-8.23 
Return on Assets:-0.34 
Return on Equity:-0.54 
EPS Ratio:-0.20 
Revenue:9.46M 
Shares:371.93M 
Market Cap:1.25B 

TECHNICAL INDICATORS

MA5:3.262.9%
MA10:3.195.4%
MA20:3.214.6%
MA50:3.9216.8%
MA100:3.8615.0%
MA200:3.234.1%
STO9:55.00
STO14:55.00
RSI14:61.11 
MTM14:0.32
ROC14:0.11 
ATR:0.23 
Week High:3.7210.7%
Week Low:2.9215.1%
Month High:3.8213.7%
Month Low:2.914.1%
Year High:5.8774.7%
Year Low:1.43135.0%